SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-000480
Filing Date
2013-02-05
Accepted
2013-02-05 07:37:58
Documents
4
Period of Report
2013-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50553536.htm 8-K 37749
2 EXHIBIT 10.1 a50553536ex10_1.htm EX-10.1 639621
3 EXHIBIT 99.1 a50553536ex99_1.htm EX-99.1 27894
4 GRAPHIC opexa-logo.jpg GRAPHIC 5610
  Complete submission text file 0001157523-13-000480.txt   714596
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 13572016
SIC: 2834 Pharmaceutical Preparations